Warren Nighan

Track

Insider profile

Currently holds a position at AngioDynamics Inc

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 102%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Senior Vice President Quality and Regulatory Affairs AngioDynamics Inc April 1, 2017 -
Executive Vice President - Quality Assurance and Regulatory Assurance Haemonetics Corp Jan. 1, 2013 - Dec. 1, 2013
Vice President - Worldwide Quality & Regulatory Affairs Haemonetics Corp Nov. 17, 2010 - Jan. 1, 2013
Warren Nighan's trades of AngioDynamics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-31 2026-07-30
S Sale
649 -7.6%
376.71
US$1,939,314 		649 -7.6% 376.71 US$1,939,314
2026-07-30 2026-07-30
PrS Proposed sale
16,983
90.57
US$4,824,474 		16,983 90.57 US$4,824,474
2025-01-17 2025-01-16
S Sale
80,899 +17.7%
332.30
US$2,390,527 		80,899 +17.7% 332.30 US$2,390,527
2025-01-16 2025-01-16
PrS Proposed sale
4,060
12.31
US$49,979 		4,060 12.31 US$49,979
2024-10-10 2024-10-10
B Purchase
100 +0.2%
6.08
US$608 		100 +0.2% 6.08 US$608
2024-10-10 2024-10-07
B Purchase
768 +1.7%
6.09
US$4,677 		768 +1.7% 6.09 US$4,677